An FcγRIIa-binding peptide that mimics the interaction between FcγRIIa and IgG

Molecular Immunology

Volumn 45, Issue 2, 2008, Pages 307-319

  Cendron, Angela C ^a   Wines, Bruce D ^a   Brownlee, Robert T C ^b   Ramsland, Paul A ^a   Pietersz, Geoffrey A ^a   Hogarth, P Mark ^a  

^a BURNET INSTITUTE   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

Disulphide constrained peptides; Fc receptor; NMR; Phage display

Indexed keywords

CYSTEINYLTRYPTOPHANYLPROLYLGLYCYLTRYPTOPHANYLASPARTYLLEUCYLASPARAGINYLCYSTEINYLGLYCYLGLYCYLGLYCYLSERINAMIDE; FC RECEPTOR; FC RECEPTOR IIA; IMMUNOGLOBULIN G; PEPTIDE; PEPTIDE LIBRARY; PROLINE; TRYPTOPHAN; UNCLASSIFIED DRUG; DISULFIDE; IMMUNOGLOBULIN E RECEPTOR; LEUKOCYTE ANTIGEN; MS4A2 PROTEIN, HUMAN; SERUM ALBUMIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; BACTERIOPHAGE; CELL CLONE; CHEMICAL STRUCTURE; CHEMISTRY; CONSENSUS SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PROCEDURES; HUMAN; METABOLISM; MOLECULAR GENETICS; MOLECULAR MIMICRY; MUTAGENESIS; PROTEIN SECONDARY STRUCTURE; SURFACE PROPERTY;

AMINO ACID SEQUENCE; ANTIGENS, CD; BACTERIOPHAGES; BIOSENSING TECHNIQUES; CLONE CELLS; CONSENSUS SEQUENCE; DISULFIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, IGE; RECEPTORS, IGG; SERUM ALBUMIN; SURFACE PROPERTIES;

EID: 34548233278     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.06.152     Document Type: Article

References (65)

1. Bax A., and Davis D.G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65 (1985) 355-360
2. Bax A., and Davis D.G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63 (1985) 207-213
3. Bax A., Ikura M., Kay L.E., Torchia D.A., and Tschudin R. Comparison of different modes of two-dimensional reverse-correlation NMR for the study of proteins. J. Magn. Reson. 86 (1990) 304-318
4. Berntzen G., Brekke O.H., Mousavi S.A., Andersen J.T., Michaelsen T.E., Berg T., Sandlie I., and Lauvrak V. Characterization of an FcgammaRI-binding peptide selected by phage display. Protein Eng. Des. Sel. 19 (2006) 121-128
5. Bhattacharyya R., and Chakrabarti P. Stereospecific interactions of proline residues in protein structures and complexes. J. Mol. Biol. 331 (2003) 925-940
6. Brett P.J., Tiwana H., Feavers I.M., and Charalambous B.M. Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses. J. Biol. Chem. 277 (2002) 20468-20476
7. Brun J.G., Madland T.M., and Vedeler C.A. Immunoglobulin G fc-receptor (FcgammaR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. J. Rheumatol. 29 (2002) 1135-1140
8. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., and Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Cryst. D54 (1998) 905-921
9. Carlsson L.E., Santoso S., Baurichter G., Kroll H., Papenberg S., Eichler P., Westerdaal N.A., Kiefel V., van de Winkel J.G., and Greinacher A. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood 92 (1998) 1526-1531
10. Chirinos-Rojas C.L., Steward M.W., and Partidos C.D. A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope. Immunology 96 (1999) 109-113
11. Craig L., Sanschagrin P.C., Rozek A., Lackie S., Kuhn L.A., and Scott J.K. The role of structure in antibody cross-reactivity between peptides and folded proteins. J. Mol. Biol. 281 (1998) 183-201
12. Cwirla S.E., Peters E.A., Barrett R.W., and Dower W.J. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6378-6382
13. Deshayes K., Schaffer M.L., Skelton N.J., Nakamura G.R., Kadkhodayan S., and Sidhu S.S. Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function. Chem. Biol. 9 (2002) 495-505
14. Dijstelbloem H.M., Bijl M., Fijnheer R., Scheepers R.H., Oost W.W., Jansen M.D., Sluiter W.J., Limburg P.C., Derksen R.H., van de Winkel J.G., and Kallenberg C.G. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum. 43 (2000) 2793-2800
15. Dijstelbloem H.M., van de Winkel J.G., and Kallenberg C.G. Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol. 22 (2001) 510-516
16. Engh R.A., and Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Cryst. A47 (1991) 392-400
17. England B.P., Balasubramanian P., Uings I., Bethell S., Chen M.J., Schatz P.J., Yin Q., Chen Y.F., Whitehorn E.A., Tsavaler A., Martens C.L., Barrett R.W., and McKinnon M. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6862-6867
18. Fan Z.C., Shan L., Guddat L.W., He X.M., Gray W.R., Raison R.L., and Edmundson A.B. Three-dimensional structure of an Fv from a human IgM immunoglobulin. J. Mol. Biol. 228 (1992) 188-207
19. Ferrieres G., Villard S., Pugniere M., Mani J.C., Navarro-Teulon I., Rharbaoui F., Laune D., Loret E., Pau B., and Granier C. Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display role of sequences flanking thebinding motif. Eur. J. Biochem. 267 (2000) 1819-1829
20. Garman S.C., Kinet J.P., and Jardetzky T.S. Crystal structure of the human high-affinity IgE receptor. Cell 95 (1998) 951-961
21. Garman S.C., Wurzburg B.A., Tarchevskaya S.S., Kinet J.-P., and Jardetzky T.S. Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha. Nature 406 (2000) 259-266
22. Goddard T.D., and Kneller D.G. Sparky 3 (2004), University of California, San Francisco, USA
23. Goldsmith E.B., Erickson B.W., and Thompson N.L. Synthetic peptides from mouse Fc receptor (MoFc gamma RII) that alter the binding of IgG to MoFc gamma RII. Biochemistry 36 (1997) 952-959
24. Hibbs M.L., Tolvanen M., and Carpen O. Membrane-proximal Ig-like domain of Fc gamma RIII (CD16) contains residues critical for ligand binding. J. Immunol. 152 (1994) 4466-4474
25. Hogarth P.M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 14 (2002) 798-802
26. Hulett M.D., and Hogarth P.M. Molecular basis of Fc receptor function. Adv. Immunol. 57 (1994) 1-127
27. Hulett M.D., McKenzie I.F., and Hogarth P.M. Chimeric Fc receptors identify immunoglobulin-binding regions in human Fc gamma RII and Fc epsilon RI. Eur. J. Immunol. 23 (1993) 640-645
28. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F., and Hogarth P.M. Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. J. Biol. Chem. 269 (1994) 15287-15293
29. Hulett M.D., Witort E., Brinkworth R.I., McKenzie I.F., and Hogarth P.M. Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG. J. Biol. Chem. 270 (1995) 21188-21194
30. Hutchinson E.G., and Thornton J.M. A revised set of potentials for beta-turn formation in proteins. Protein Sci. 3 (1994) 2207-2216
31. Ierino F.L., Hulett M.D., McKenzie I.F., and Hogarth P.M. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors. J. Immunol. 150 (1993) 1794-1803
32. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14 (1996) 51-55
33. Liu M., Mao X., Ye C., Huang H., Nicholson J.K., and Lindon J.C. Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy. J. Magn. Reson. 132 (1998) 125-129
34. Manger K., Repp R., Spriewald B.M., Rascu A., Geiger A., Wassmuth R., Westerdaal N.A., Wentz B., Manger B., Kalden J.R., and van de Winkel J.G. Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms. Arthritis Rheum. 41 (1998) 1181-1189
35. Marino M., Ruvo M., De Falco S., and Fassina G. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide. Nat. Biotechnol. 18 (2000) 735-739
36. Maxwell K.F., Powell M.S., Hulett M.D., Barton P.A., McKenzie I.F., Garrett T.P., and Hogarth P.M. Crystal structure of the human leukocyte Fc receptor Fc gammaRIIa. Nat. Struct. Biol. 6 (1999) 437-442
37. McDonnell J.M., Beavil A.J., Mackay G.A., Jameson B.A., Korngold R., Gould H.J., and Sutton B.J. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat. Struct. Biol. 3 (1996) 419-426
38. McKenzie S.E., Taylor S.M., Malladi P., Yuhan H., Cassel D.L., Chien P., Schwartz E., Schreiber A.D., Surrey S., and Reilly M.P. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J. Immunol. 162 (1999) 4311-4318
39. Medgyesi D., Uray K., Sallai K., Hudecz F., Koncz G., Abramson J., Pecht I., Sarmay G., and Gergely J. Functional mapping of the Fc gamma RII binding site on human IgG1 by synthetic peptides. Eur. J. Immunol. 34 (2004) 1127-1135
40. Moser K.L., Neas B.R., Salmon J.E., Yu H., Gray-McGuire C., Asundi N., Bruner G.R., Fox J., Kelly J., Henshall S., Bacino D., Dietz M., Hogue R., Koelsch G., Nightingale L., Shaver T., Abdou N.I., Albert D.A., Carson C., Petri M., Treadwell E.L., James J.A., and Harley J.B. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14869-14874
41. Nakamura G.R., Starovasnik M.A., Reynolds M.E., and Lowman H.B. A novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor. Biochemistry 40 (2001) 9828-9835
42. Nakamura G.R., Reynolds M.E., Chen Y.M., Starovasnik M.A., and Lowman H.B. Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1303-1308
43. Piotto M., Saudek V., and Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2 (1992) 661-665
44. Radaev S., and Sun P.D. Recognition of IgG by Fcgamma receptor the role of Fc glycosylation and the binding of peptide inhibitors. J. Biol. Chem. 276 (2001) 16478-16483
45. Radaev S., Motyka S., Fridman W.H., Sautes-Fridman C., and Sun P.D. The structure of a human type III Fcgamma receptor in complex with Fc. J. Biol. Chem. 276 (2001) 16469-16477
46. Ramachandran G.N., and Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23 (1968) 283-438
47. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., Ramsey-Goldman R., Peterson M.G., and Kimberly R.P. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97 (1996) 1348-1354
48. Sheridan J.M., Hayes G.M., and Austen B.M. Solid-phase synthesis and cyclization of a large branched peptide from IgG Fc with affinity for Fc gammaRI. J. Pept. Sci. 5 (1999) 555-562
49. Shields R.L., Namenuk A.K., Hong K., Meng Y.G., Rae J., Briggs J., Xie D., Lai J., Stadlen A., Li B., Fox J.A., and Presta L.G. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J. Biol. Chem. 276 (2001) 6591-6604
50. Sondermann P., Huber R., and Jacob U. Crystal structure of the soluble form of the human fcgamma-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution. Embo J. 18 (1999) 1095-1103
51. Sondermann P., Huber R., Oosthuizen V., and Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406 (2000) 267-273
52. Sondermann P., Kaiser J., and Jacob U. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. J. Mol. Biol. 309 (2001) 737-749
53. Stamos J., Eigenbrot C., Nakamura G.R., Reynolds M.E., Yin J., Lowman H.B., Fairbrother W.J., and Starovasnik M.A. Convergent recognition of the IgE binding site on the high-affinity IgE receptor. Structure 12 (2004) 1289-1301
54. Takahashi M., Ohgitani Y., Ueno A., and Mihara H. Design of peptides derived from anti-IgE antibody for allergic treatment. Bioorg. Med. Chem. Lett. 9 (1999) 2185-2188
55. Tamm A., Kister A., Nolte K.U., Gessner J.E., and Schmidt R.E. The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain. J. Biol. Chem. 271 (1996) 3659-3666
56. Tan Sardjono C., Mottram P.L., and Hogarth P.M. The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol. Cell Biol. 81 (2003) 374-381
57. Taylor S.M., Reilly M.P., Schreiber A.D., Chien P., Tuckosh J.R., and McKenzie S.E. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor. Blood 96 (2000) 4254-4260
58. Uray K., Medgyesi D., Hilbert A., Sarmay G., Gergely J., and Hudecz F. Synthesis and receptor binding of IgG1 peptides derived from the IgG Fc region. J. Mol. Recognit. 17 (2004) 95-105
59. van Sorge N.M., van der Pol W.L., and van de Winkel J.G. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61 (2003) 189-202
60. Warmerdam P.A., van de Winkel J.G., Gosselin E., and Capel P.J. Molecular basis for a polymorphism of human Fcγ Receptor II (CD32). J. Exp. Med. 172 (1990) 19-25
61. Warmerdam P.A., van de Winkel J.G., Vlug A., Westerdaal N.A., and Capel P.J. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J. Immunol. 147 (1991) 1338-1343
62. Williams Y., Lynch S., McCann S., Smith O., Feighery C., and Whelan A. Correlation of platelet Fc gammaRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura. Br. J. Haematol. 101 (1998) 779-782
63. Wines B.D., Powell M.S., Parren P.W., Barnes N., and Hogarth P.M. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A. J. Immunol. 164 (2000) 5313-5318
64. Zhang Y., Boesen C.C., Radaev S., Brooks A.G., Fridman W.H., Sautes-Fridman C., and Sun P.D. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity 13 (2000) 387-395
65. Zwick M.B., Bonnycastle L.L., Menendez A., Irving M.B., Barbas III C.F., Parren P.W., Burton D.R., and Scott J.K. Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12. J. Virol. 75 (2001) 6692-6699